Previously, ERβ was recognized as a prognostic factor in breast cancer (18), and plays a protective role in a variety of tumors, such as lung cancer, colon cancer, and breast carcinoma (19, 20, 21, 22). Here, ESR2 is linked to breast carcinoma.